Elite Health Systems (EHSI) EBITDA (2010 - 2026)

Elite Health Systems has disclosed EBITDA across 17 years of filings, most recently posting -$1.3 million for Q1 2026.

• In Q1 2026, EBITDA fell 203.98% year-over-year to -$1.3 million; the TTM figure through Mar 2026 stood at -$4.7 million (down 1027.03% YoY), while the FY2025 annual figure was -$3.8 million, down 723.82% from the prior year.
• EBITDA climbed to -$1.3 million in Q1 2026, from -$1.8 million in the prior quarter.
• Over the last five years, EBITDA for EHSI reached as high as $833000.0 in Q4 2024 and fell as low as -$1.8 million in Q4 2025.
• The 5-year median for EBITDA is -$387000.0 (2024), against an average of -$420352.9.
• Annual changes were most pronounced in 2023 — EBITDA surged 171.46% — and 2025, when it tumbled 316.45%.
• A 5-year view of EBITDA shows it stood at -$508000.0 in 2022, then surged by 171.46% to $363000.0 in 2023, then surged by 129.48% to $833000.0 in 2024, then plunged by 316.45% to -$1.8 million in 2025, then grew by 28.01% to -$1.3 million in 2026.
• According to Business Quant data, EBITDA over the past three periods registered -$1.3 million, -$1.8 million, and -$1.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.